Medical oncologist, Palliative medicine doctor, Thoracic specialist, Internal medicine doctor
Dr. Ramchandran is recognized for her contributions as a leader in the integration of palliative and oncology care. Dr. Ramchandran is one of a small number of dual trained faculty who are working to build synergies between the fields of oncology and palliative medicine in the areas of supportive care research, and novel models of care. She now serves as Stanford Cancer Institute’s Transformation Design lead for improving the palliative care experience for patients with a cancer diagnosis. She is also the Medical Director of Palliative Medicine at Stanford Cancer Institute.
In her care of patients Dr. Ramchandran values a deep relationship with the families she cares for. She provides care that is aligned with the patient and family's personal values with the goal of the best quality of life possible.
Dr. Ramchandran’s research focuses on developing care delivery models that incorporate values (patients, family members, and clinicians), as well as novel means of palliative care education. She also is part of an active thoracic oncology trials group recruiting patients for clinical trials using novel therapeutics.
Dr. Ramchandran currently serves on the Patient and Survivor Care Committee for the American Society of Clinical Oncology and the National Comprehensive Cancer Network Palliative Care task force. She serves as a clinician in thoracic oncology and in palliative medicine at Stanford Cancer Institute.
- Board Certification: Hospice and Palliative Medicine, American Board of Internal Medicine (2012)
- Board Certification: Medical Oncology, American Board of Internal Medicine (2010)
- Fellowship: Northwestern University - Department of Medicine Feinberg School of Medicine (2009) IL
- Board Certification: Internal Medicine, American Board of Internal Medicine (2007)
- Residency: UCSF-Internal Medicine (2007) CA
- Medical Education: University of California at San Francisco School of Medicine (2004) CA
- Board Certification, Oncology, Oncology (2009)
Honors & Awards
- Honoree, AACR/ASCO: Methods in Clinical Cancer Research (2009)
- Honoree, Clinical Effectiveness Leadership Training- CELT (2014)
- Nominee, Medical Residency Teaching Award (2012)
- Medical Director, Palliative Medicine, Stanford Cancer Institute (2012 - Present)
My Friend, My Patient
Ramchandran, K. (2009). My Friend, My Patient. JOURNAL OF PALLIATIVE MEDICINE, 12(1), 95–96.
Sex Differences in Susceptibility to Carcinogens
Ramchandran, K., & Patel, J. D. (2009). Sex Differences in Susceptibility to Carcinogens. SEMINARS IN ONCOLOGY, 36(6), 516–523.
Phantom Limb Pain #212
Ramchandran, K., & Hauser, J. (2010). Phantom Limb Pain #212. JOURNAL OF PALLIATIVE MEDICINE, 13(10), 1285–1286.
Emerging Concepts in the Pathology and Molecular Biology of Advanced Non-Small Cell Lung Cancer
Kulesza, P., Ramchandran, K., & Patel, J. D. (2011). Emerging Concepts in the Pathology and Molecular Biology of Advanced Non-Small Cell Lung Cancer. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 136(2), 228–238.
A predictive model to identify hospitalized cancer patients at risk for 30-day mortality based on admission criteria via the electronic medical record.
Ramchandran, K. J., Shega, J. W., von Roenn, J., Schumacher, M., Szmuilowicz, E., Rademaker, A., … Weitzman, S. (2013). A predictive model to identify hospitalized cancer patients at risk for 30-day mortality based on admission criteria via the electronic medical record. Cancer, 119(11), 2074–2080.
Palliative Care Always
Ramchandran, K., & Von Roenn, J. H. (2013). Palliative Care Always. ONCOLOGY-NEW YORK, 27(1), 13-?
Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era.
Riess, J. W., Nagpal, S., Iv, M., Zeineh, M., Gubens, M. A., Ramchandran, K., … Wakelee, H. A. (2014). Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era. Clinical Lung Cancer, 15(3), 202–206.
Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancer†.
Lee, R. T., Ramchandran, K., Sanft, T., & Von Roenn, J. (2015). Implementation of supportive care and best supportive care interventions in clinical trials enrolling patients with cancer†. Annals of Oncology , 26(9), 1838–1845.
Integrated Palliative Care and Oncologic Care in Non-Small-Cell Lung Cancer.
Chandrasekar, D., Tribett, E., & Ramchandran, K. (2016). Integrated Palliative Care and Oncologic Care in Non-Small-Cell Lung Cancer. Current Treatment Options in Oncology, 17(5), 23-?
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.